2024 Cell Therapy Market Opportunities

Despite manufacturing and other logistical challenges, the cell therapy pipeline continues to expand.​

Extensive proof of concept and competition in hematological cancers has triggered interest in novel applications such as autoimmune disease and solid tumors…​

…As well as differentiation to enhance safety and reduce manufacturing costs, through cost-effect delivery alternatives such as nanoparticles.​

Hence, much like the 1st generation of cell therapies, it is more important than ever to optimize R&D strategy and be first-to-market​.

These insights and market knowledge have been developed based on the analysis and fusion of data collated from a variety of sources by the Hanson Wade Intelligence team, elevating the quality of insights compared to Beacon data alone​.

• Beacon Cell Therapy database: Vast repository of highly granular, current and historical data on cell therapy assets; exploration by the Hanson Wade Intelligence of its deepest recesses and use of smart interpretation facilitates in-depth understanding of trends and trajectories at quantitative scale, and over long time periods.

• External sources: Datapoints from additional external sources were used to complement existing Beacon data; clever inference and data fusion was used to increase the relevance and meaning of the outputs, enabling a higher quality of insights​.